Status:

UNKNOWN

Optimize Low Back Pain

Lead Sponsor:

University of Utah

Collaborating Sponsors:

Patient-Centered Outcomes Research Institute

Conditions:

Low Back Pain

Chronic Pain

Eligibility:

All Genders

18-64 years

Phase:

PHASE3

Brief Summary

The objective of this study is to improve health care for patients with chronic LBP and increase the likelihood that patients obtain outcomes that matter most to them. The investigators will accomplis...

Detailed Description

The study uses a sequential multiple randomization (SMART) design. The study will compare the effectiveness of common first-line treatments for chronic LBP: PT or CBT. Initial treatment will be 8 week...

Eligibility Criteria

Inclusion

  • Age 18 - 64 years at the time of enrollment.
  • Meets NIH Task Force definition of chronic LBP based on two questions: 1) How long has LBP has been an ongoing problem for you? and 2) How often has LBP been an ongoing problem for you over the past 6 months? A response of greater than 3 months to question 1, and "at least half the days in the past 6 months" to question 2 is required to satisfy the NIH definition of chronic LBP.
  • Healthcare visit for LBP in the past 90 days.
  • At least moderate levels of pain and disability requiring ODI score \>24 and pain intensity rating \> 4.
  • Has access to two-way video technology, such as smartphone, iPad/tablet, or laptop with webcam for telehealth visits.

Exclusion

  • Evidence of serious pathology as a cause of LBP including neoplasm, inflammatory disease (e.g., ankylosing spondylitis), vertebral osteomyelitis, etc.
  • Evidence of a specific spinal pathology as the cause of LBP including spine fracture, spinal stenosis, radiculopathy, etc.
  • Knowingly pregnant
  • Has received physical therapy for LBP; or CBT or mindfulness for any reason with a provider in prior 90 days
  • Currently receiving substance use disorder treatment
  • Any lumbar spine surgery in the past year.

Key Trial Info

Start Date :

March 22 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2024

Estimated Enrollment :

748 Patients enrolled

Trial Details

Trial ID

NCT03859713

Start Date

March 22 2019

End Date

September 1 2024

Last Update

October 4 2023

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Johns Hopkins University

Baltimore, Maryland, United States, 21287

2

Intermountain Health Care

Salt Lake City, Utah, United States, 84107

3

The University of Utah Healthcare System

Salt Lake City, Utah, United States, 84108